4Sarosi G A. Amphtericin B. still the glod standard for antigungal therapy. Postgrad Med, 1990; 88 ( 7 ): 151
5Terrell C L, Hughes C E. Antifungal agents used for deepseatded mycobic infections. Mayo Clin Proc, 1992; 67( 1 ) 69
6Chen SC. Cryptococcsis in Australia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother ,2002,49 (S1): S57-61.
7Saag MS,Graybill RJ,Larsen RA,et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis,2000,30(4):710 -718.
8Barchiesi F, Schimizzi AM, Caselli F, et al. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother, 2000,44 ( 9 ): 2435-2441.
9Li RK, Rinaldi MG. In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother,1999,43(6): 1401-1405.
10Stevens DA. Combination immunotherapy and antifungal chemotherapy.Clin Infect Dis, 1998,26(6) :1266 -1269.
